HLA-J as a new predictive marker in breast cancer for neoadjuvant chemotherapy

被引：0
|
作者：
Wuerfel, F. M. [1 ]
Wirtz, R. M. [1 ]
Winterhalter, C. [2 ]
De Laco, P. [3 ]
Rosati, M. [3 ]
Veltrup, E. [1 ]
Martoni, A. A. [3 ]
Wuerfel, W. [2 ]
Zamagni, C. [3 ]
机构：
[1] Stratifyer Mol Pathol GmbH, Cologne, Germany
[2] Intellexon GmbH, Pocking, Germany
[3] St Orsola Marcello Malpighi Hosp, Obstet & Gynaecol Unit, Bologna, Italy
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1717881
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P049
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [21] TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Zhang, Pin
    Li, Qing
    Ma, Fei
    Fan, Ying
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 531 - 537
  • [22] TrkC:: A new predictive marker in breast cancer?
    Blasco-Gutierrez, Maria Jesus
    Jose-Crespo, Isabel Julia San
    Zozaya-Alvarez, Enrique
    Ramos-Sanchez, Rafael
    Garcia-Atares, Natividad
    CANCER INVESTIGATION, 2007, 25 (06) : 405 - 410
  • [23] Analysis of Tumor Marker Response of Breast Cancer in the Setting of Neoadjuvant Chemotherapy
    Duggal, S.
    Erb, K.
    Julian, T. B.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S70 - S70
  • [24] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
    I F Faneyte
    J G Schrama
    J L Peterse
    P L Remijnse
    S Rodenhuis
    M J van de Vijver
    British Journal of Cancer, 2003, 88 : 406 - 412
  • [25] Predictive Role of GSTs on the Prognosis of Breast Cancer Patients with Neoadjuvant Chemotherapy
    Bai, Yun-Lu
    Zhou, Bing
    Jing, Xiao-Yue
    Zhang, Bin
    Huo, Xiao-Qing
    Ma, Chao
    He, Jian-Miao
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5019 - 5022
  • [26] Serum proteins as predictive markers of the response to neoadjuvant chemotherapy for breast cancer
    Steenbuck, Ines Derya
    Cosenza, Miguel
    Froehlich, Klemens
    Mayer, Bettina
    Werner, Tilman
    Jaeger, Markus
    Weiss, Daniela
    Noething, Claudia
    Schilling, Oliver
    Erbes, Thalia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 14 - 14
  • [27] Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer
    Kim, Min Ji
    Eun, Na Lae
    Ahn, Sung Gwe
    Kim, Jee Hung
    Youk, Ji Hyun
    Son, Eun Ju
    Jeong, Joon
    Cha, Yoon Jin
    Bae, Soong June
    CANCERS, 2024, 16 (02)
  • [28] Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy
    Buchholz, TA
    Hill, BS
    Tucker, SL
    Frye, DK
    Kuerer, HM
    Buzdar, AU
    McNeese, MD
    Singletary, SE
    Ueno, NT
    Pusztai, L
    Valero, V
    Hortobagyi, GN
    CANCER JOURNAL, 2001, 7 (05): : 413 - 420
  • [29] Predictive factors of pathological response to neoadjuvant chemotherapy in patients with breast cancer
    Ryspayeva, Dinara
    Lyashenko, Andrey
    Dosenko, Irina
    Kostryba, Oleksey
    Koshyk, Olena
    Krotevych, Mykhailo
    Smolanka, Ivan
    JOURNAL OF BUON, 2020, 25 (01): : 168 - 175
  • [30] PREDICTIVE AND PROGNOSTIC SIGNIFICANCE OF TOPO IIα IN NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER
    Chen, S.
    Huang, L.
    Liu, Y.
    Yu, K.
    Shao, Z.
    BREAST, 2013, 22 : S49 - S49
12345